<?xml version="1.0" encoding="utf-8"?>
<root>
	<status>success</status>
	<message>The QUALITY_ASSURE field for indicator 3-3-5, translated into en</message>
	<data>&lt;h2&gt;Quality assurance:&lt;/h2&gt;
&lt;p&gt;Training materials for the Integrated NTD database are available here: &lt;a href=&quot;http://www.who.int/neglected_diseases/data/ntddatabase/en/&quot;&gt;http://www.who.int/neglected_diseases/data/ntddatabase/en/&lt;/a&gt;. A user guide and video tutorial for the joint reporting mechanism and set of reporting forms are available here: &lt;a href=&quot;http://www.who.int/neglected_diseases/preventive_chemotherapy/reporting/en/&quot;&gt;http://www.who.int/neglected_diseases/preventive_chemotherapy/reporting/en/&lt;/a&gt;&lt;/p&gt;
&lt;p&gt;Details about individual NTD data are available via: &lt;a href=&quot;http://www.who.int/gho/neglected_diseases/en/&quot;&gt;http://www.who.int/gho/neglected_diseases/en/&lt;/a&gt;. For NTDs requiring preventive chemotherapy, reports are signed by the NTD coordinator or a Ministry of Health representative to formally endorse the country&amp;#x2019;s request for medicines (when applicable) and data. They are submitted to the WHO Representative of the concerned WHO Country office.&lt;/p&gt;</data>
</root>
